Sudipto Das
Overview
Explore the profile of Sudipto Das including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
3043
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rodriguez-Sosa A, Lawal O, McDonnell C, Grant L, OBrien J, Ali M, et al.
Gastro Hep Adv
. 2025 Feb;
4(3):100586.
PMID: 39944929
Background And Aims: Primary sclerosing cholangitis (PSC) is a progressive cholestatic disease with up to 80% of patients also suffering from ulcerative colitis (PSC-UC). The difficulty in the diagnosis along...
2.
Connelly K, Hullin K, Abdolalizadeh E, Zhong J, Eiser D, OBrien A, et al.
medRxiv
. 2024 Oct;
PMID: 39371158
Pancreatic Ductal Adenocarcinoma (PDAC) is the third leading cause of cancer-related deaths in the U.S. Both rare and common germline variants contribute to PDAC risk. Here, we fine-map and functionally...
3.
Xu G, Cong Y, Das S
Biochim Biophys Acta Gene Regul Mech
. 2024 Sep;
1867(4):195060.
PMID: 39243855
No abstract available.
4.
Kerrigan L, Edgar K, Russell-Hallinan A, Cappa O, Glezeva N, Galan-Arriola C, et al.
ESC Heart Fail
. 2024 Sep;
12(1):150-165.
PMID: 39233619
Aims: Dynamic alterations in cardiac DNA methylation have been implicated in the development of heart failure (HF) with evidence of ischaemic heart disease (IHD); however, there is limited research into...
5.
Das S, Das S, Mandal S
Phys Rev Lett
. 2024 Mar;
132(10):106501.
PMID: 38518319
A proposal of the existence of an Anomalous phase (A phase) [Das et al., Phys. Rev. Lett. 131, 056202 (2023)PRLTAO0031-900710.1103/PhysRevLett.131.056202] at the experimental range of moderate Landau-level-mixing strength has recently...
6.
Lu X, Chandravanshi M, Sabbasani V, Gaikwad S, Hughitt V, Gyabaah-Kessie N, et al.
Nat Commun
. 2024 Mar;
15(1):2485.
PMID: 38509117
Proteasome subunit hRpn13 is partially proteolyzed in certain cancer cell types to generate hRpn13 by degradation of its UCHL5/Uch37-binding DEUBAD domain and retention of an intact proteasome- and ubiquitin-binding Pru...
7.
Das S, Das S, Mandal S
Phys Rev Lett
. 2024 Jan;
132(2):029602.
PMID: 38277593
No abstract available.
8.
Osei-Amponsa V, Chandravanshi M, Lu X, Magidson V, Das S, Andresson T, et al.
Mol Cell
. 2023 Dec;
84(3):522-537.e8.
PMID: 38151017
The anti-cancer target hRpn13 is a proteasome substrate receptor. However, hRpn13-targeting molecules do not impair its interaction with proteasomes or ubiquitin, suggesting other critical cellular activities. We find that hRpn13...
9.
Finnegan E, Ding W, Ude Z, Terer S, McGivern T, Blumel A, et al.
Cell Oncol (Dordr)
. 2023 Nov;
47(2):533-553.
PMID: 37934338
Purpose: The histone deacetylase inhibitor (HDACi), belinostat, has had limited therapeutic impact in solid tumors, such as colon cancer, due to its poor metabolic stability. Here we evaluated a novel...
10.
Yang M, Mariano J, Su R, Smith C, Das S, Gill C, et al.
J Biol Chem
. 2023 Oct;
299(12):105346.
PMID: 37838170
Nsp3s are the largest nonstructural proteins of coronaviruses. These transmembrane proteins include papain-like proteases (PLpro) that play essential roles in cleaving viral polyproteins into their mature units. The PLpro of...